IE42765L - Treatment of circulatory disorders - Google Patents
Treatment of circulatory disordersInfo
- Publication number
- IE42765L IE42765L IE760010A IE1076A IE42765L IE 42765 L IE42765 L IE 42765L IE 760010 A IE760010 A IE 760010A IE 1076 A IE1076 A IE 1076A IE 42765 L IE42765 L IE 42765L
- Authority
- IE
- Ireland
- Prior art keywords
- treatment
- circulatory disorders
- phentolamine
- gb1500300a
- geigy
- Prior art date
Links
- MRBDMNSDAVCSSF-UHFFFAOYSA-N phentolamine Chemical compound C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 MRBDMNSDAVCSSF-UHFFFAOYSA-N 0.000 abstract 2
- 229960001999 phentolamine Drugs 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1500300 Compositions containing phentolamine CIBA - GEIGY AG 31 Dec 1975 [6 Jan 1975 13 Nov 1975] 53294/75 Heading A5B Pharmaceutical preparations which can be used orally are characterised by a slow and continuous release of phentolamine or a pharmaceutically usable salt thereof.
[GB1500300A]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH7175 | 1975-01-06 | ||
| CH1474775 | 1975-11-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE42765L true IE42765L (en) | 1976-07-06 |
| IE42765B1 IE42765B1 (en) | 1980-10-08 |
Family
ID=25683420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE10/76A IE42765B1 (en) | 1975-01-06 | 1976-01-05 | Pharmaceutical preparation for the treatment of circulatory disorders |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS5191314A (en) |
| AU (1) | AU499139B2 (en) |
| BE (1) | BE837294A (en) |
| CA (1) | CA1059914A (en) |
| DE (1) | DE2600021A1 (en) |
| FR (1) | FR2296415A1 (en) |
| GB (1) | GB1500300A (en) |
| IE (1) | IE42765B1 (en) |
| IL (1) | IL48787A (en) |
| NL (1) | NL7600047A (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI63335B (en) * | 1979-02-02 | 1983-02-28 | Orion Yhtymae Oy | FARING REFERENCE FOR A TABLETTER WITH A LIGHT LIGHT OF AN EFFECTIVE |
| NZ195933A (en) * | 1980-01-11 | 1982-11-23 | Boots Co Ltd | Sustained-release pharmaceutical compositions in tablet form |
| US5731339A (en) * | 1995-04-28 | 1998-03-24 | Zonagen, Inc. | Methods and formulations for modulating the human sexual response |
| FI20060501A7 (en) * | 2006-05-22 | 2007-11-23 | Biohit Oyj | Composition and method for binding acetaldehyde in the stomach |
| WO2008013084A1 (en) * | 2006-07-25 | 2008-01-31 | Kowa Company, Ltd. | Sugar-coated preparation and process for producing the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL51480C (en) * | ||||
| FR1013681A (en) * | 1947-01-31 | 1952-08-01 | Ciba Geigy | New imidazolines and process for their manufacture |
-
1975
- 1975-12-31 GB GB53294/75A patent/GB1500300A/en not_active Expired
-
1976
- 1976-01-02 CA CA242,910A patent/CA1059914A/en not_active Expired
- 1976-01-02 DE DE19762600021 patent/DE2600021A1/en not_active Withdrawn
- 1976-01-02 FR FR7600014A patent/FR2296415A1/en active Granted
- 1976-01-05 IE IE10/76A patent/IE42765B1/en unknown
- 1976-01-05 BE BE163296A patent/BE837294A/en unknown
- 1976-01-05 NL NL7600047A patent/NL7600047A/en unknown
- 1976-01-05 IL IL48787A patent/IL48787A/en unknown
- 1976-01-05 AU AU10001/76A patent/AU499139B2/en not_active Expired
- 1976-01-06 JP JP51000126A patent/JPS5191314A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NL7600047A (en) | 1976-07-08 |
| AU1000176A (en) | 1977-07-14 |
| IL48787A0 (en) | 1976-03-31 |
| AU499139B2 (en) | 1979-04-05 |
| FR2296415A1 (en) | 1976-07-30 |
| CA1059914A (en) | 1979-08-07 |
| DE2600021A1 (en) | 1976-07-15 |
| JPS5191314A (en) | 1976-08-10 |
| GB1500300A (en) | 1978-02-08 |
| IE42765B1 (en) | 1980-10-08 |
| FR2296415B1 (en) | 1978-08-18 |
| BE837294A (en) | 1976-07-05 |
| IL48787A (en) | 1978-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL930110I2 (en) | Carbazolyl- (4) -oxypropanolamine derivatives, method of preparation thereof and drugs containing these compounds. | |
| ES479474A1 (en) | Use of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3-beta-methoxy ethylester-5-isopropylester for the preparation of cerebrally active drugs. | |
| NL970028I1 (en) | 2 (1H) -Pyridinone derivatives and pharmaceutical preparations containing these derivatives. | |
| PT72596A (en) | Process for the preparation of new 2(1h)-pyridone derivatives having pharmaceutical effect | |
| AU526270B2 (en) | Acid addition salt of 2beta,16beta diperidino 5 alpha androstane derivatives | |
| DE2964802D1 (en) | Derivatives of 3-azabicyclo(3.1.0)hexane and processes for their preparation | |
| NL7811050A (en) | NEW CHINAZOLINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH A COMPOUND. | |
| IE42765L (en) | Treatment of circulatory disorders | |
| FR2507605B1 (en) | PROCESS FOR THE PREPARATION OF APOVINCAMINIC ACID ESTERS, ESTERS THUS OBTAINED AND PHARMACEUTICAL COMPOSITIONS PREPARED THEREWITH | |
| AU509621B2 (en) | Detection, and'Prevention of Diseases caused by N, Gonorrhoeae | |
| PH15364A (en) | 5,3-disubstituted 1h 1,2,4-thiazole derivatives their pharmaceutical compositions and method of use | |
| CA1008070A (en) | 1,4-diazacycloalkane derivatives and acid addition compounds thereof and method of making same | |
| HU186355B (en) | Fungicide and nematocide preparations containing 1,3,4-thia-diazole-2- carboxylic acid derivatives | |
| ZA793720B (en) | Substituted 2-phenylamino-imidazoline-(2)derivatives,acid addition salts thereof,processes for their preparation,and pharmaceutical compositions thereof | |
| FR2515961B1 (en) | DRUG PREPARATIONS CONTAINING A TETRAIODOTHYROCARBOXYLIC ACID DERIVATIVE, PARTICULARLY FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA | |
| NZ180863A (en) | 3,5-bisoxygenated 2-(w-halo-3-oxygenated-1-alkenyl)-cyclopentane-1-heptanoic acid derivatives and pharmaceutical compositions | |
| NZ193079A (en) | Derivatives of 1, 1'-biphenyl-2-yl-alkylamine medicinal preparations | |
| ZA793335B (en) | Derivatives of 3-azabicyclo(3.1.0)hexane and processes for their preparation | |
| PT67907A (en) | PROCESS FOR THE PREPARATION OF ACID ADDITION 2'-HYDROXY-2 AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| PT71883A (en) | PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS BASED ON AQUEOUS EXTRACTS OF RED GRAPE MARCAS | |
| DE3275645D1 (en) | N1-ACYL-3-AMINO-1,2,3,4-TETRAHYDROQUINOLINE COMPOUNDS | |
| ZA763955B (en) | 1,4-dihydropyridine derivatives process for preparation thereof and pharmaceutical composition of the same | |
| ES8304924A1 (en) | Peptide, process for preparation thereof and use thereof. | |
| AU493283B2 (en) | Process for the preparation of 9,11,15-trihydroxy-13,14-dehydro-prostaglandins and new prost-5-en-13-ynoic acid derivatives | |
| ZA793604B (en) | Substituted 2-phenylamino-imidazoline-(2)derivatives,acid addition salts thereof,processes for their preparation,and pharmaceutical compositions thereof |